Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02935751 · ClinicalTrials.gov registry record
Apixaban Discontinuation Prior to Major Surgery
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 130
- Enrollment target
NCT02935751: Completed study, sponsored by Thomas Jefferson University.
NCT02935751 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02935751 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The ADIOS study is a prospective, observational study will evaluate one hundred and thirty (130) patients with non-valvular atrial fibrillation who are currently receiving treatment with apixaban as indicated to reduce the risk of stroke or systemic embolism, and who require an elective major surgical or invasive procedure will be included in the study. The purpose of the study is to evaluate the efficacy of the recommended pre-procedure washout period of 48 hours.
Primary Outcome
Determine whether the recommended 48 hour pre-procedure discontinuation period is sufficient to achieve minimal apixaban plasma concentration of \< 30 ng/ml prior to surgery
Interventions
- OTHER Lab tests for plasma levels of apixaban and anti-10a factor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-09 |
What the finished NCT02935751 record still lists
NCT02935751 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Lab tests for plasma levels of apixaban and anti-10a factor is the first listed.
NCT02935751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02935751 about?
NCT02935751 is a clinical study titled "Apixaban Discontinuation Prior to Major Surgery". The ADIOS study is a prospective, observational study will evaluate one hundred and thirty (130) patients with non-valvular atrial fibrillation who are currently receiving treatment with apixaban as indicated to reduce the risk of stroke or systemic embolism, and who require an elective major surgic...
What is the current status of trial NCT02935751?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2016-10. Estimated completion is 2018-09.
What interventions are being tested in trial NCT02935751?
The interventions under investigation include: Lab tests for plasma levels of apixaban and anti-10a factor (OTHER).
Who is sponsoring clinical trial NCT02935751?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia